July 20, 2024

Weight-loss jabs could become the ‘new statin’ for heart treatment after US regulators approve the drug

It follows the results of a major trial which found the drug, known as semaglutide, could slash the risk of a heart attack or stroke in people with obesity by around 20 per cent.It follows the results of a major trial which found the drug, known as semaglutide, could slash the risk of a heart attack or stroke in people with obesity by around 20 per cent.Read MoreHealth News | Mail Online

Leave a Reply

Your email address will not be published. Required fields are marked *